- Home
- » Tags
- » Armodafinil
Top View
- International Dementia with Lewy Bodies Conference Fort Lauderdale, Florida, USA; December 1 – 4, 2015
- Nuvigil® /Armodafinil Provigil®/Modafinil
- PRAC Draft Agenda of Meeting 11-14 February 2019
- Armodafinil, Sunosi
- NUVIGIL® (Armodafinil) Tablets, for Oral Use, C-IV Discontinue NUVIGIL
- A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
- The Medication Guide for a Safe Recovery
- Armodafinil Useful Adjunct to CPAP in Apnea
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Modulation of Fronto-Cortical Activity by Modafinil: a Functional Imaging and Fos Study in the Rat
- Nuvigil® /Armodafinil Provigil®/Modafinil
- The Effect of Adjunctive Armodafinil on Cognitive Performance And
- (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
- Customs Tariff - Schedule Xxi - 1
- All Requests for Provigil (Modafinil) and Nuvigil (Armodafinil) Require A
- Modafinil / Armodafinil for Employer Group Plans
- Modafinil and Armodafinil
- Stimulants and Related Agents
- Armodafinil (Nuvigil) Reference Number: PA.CP.PMN.35 Effective Date: 01/18 Coding Implications Last Review Date: 04/19 Revision Log
- Stimulants and Related Agents
- Provigil®/Nuvigiltm Prior Authorization Criteria
- Auspar Attachment 1: Product Information for Nuvigil
- NUVIGIL® (Armodafinil) Tablets [C-IV] Rx Only
- Armodafinil, Modafinil
- Clinical Trial Protocol: 14-002 Amendment 3
- PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
- ERX.NPA.21 Armodafinil (Nuvigil)
- Medications for Ataxia Symptoms
- Controlled Substance Reference Table
- SURE PD3 Manual
- Nuvigil) Reference Number: CP.PMN.35 Effective Date: 08.01.09 Last Review Date: 11.20 Line of Business: Commercial, HIM, Medicaid Revision Log
- In This Issue
- Modafinil Attenuates Reinstatement of Cocaine Seeking
- Nuvigil® /Armodafinil, Provigil®/Modafinil Prior Authorization With
- The Novel Modafinil Analog, JJC8-016, As a Potential Cocaine Abuse Pharmacotherapeutic
- New Medications for the Treatment of Insomnia
- Armodafinil) Tablets, for Oral Use, C-IV And, If Appropriate, Advise Patients to Avoid Driving Or Engaging in Any Initial U.S
- Armodafinil (NUVIGIL)
- WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
- PROVIGIL / NUVIGIL (Modafinil / Armodafinil) RATIONALE FOR
- Armodafinil (Nuvigil)
- Armodafinil (Nuvigil®) and Modafinil (Provigil®) Reference Number: ERX.NSMN.08 Effective Date: 06/15 Revision Log Last Review Date: 09/16
- Stimulants and Related Agents Criteria With
- Statistical Analysis Plan Version 1.0, 05 Sep 2019
- Stimulants and Related Agents Pa Summary
- Nuvigil® (Armodafinil) & Provigil® (Modafinil) Prior Authorization Request Form (Page 1 of 2) DO NOT COPY for FUTURE USE
- ADHD/Anti-Narcolepsy: Stimulants – Misc – Armodafinil/Modafinil Medical Policy No
- Does the Use of Oral Amphetamines Reduce Cocaine Use in Cocaine-Dependent Individuals? Kevin M